Entera Bio Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.14

+0.03 (+2.70%)

As of Apr 1, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,721.9% upside

Low Target $34.30

Average Target $43.57

High Target $49.66

Current Price $1.14

Current
$1.14

Target
$43.57

$34.30 $43.57 avg $49.66

Scenario Analysis

Bear Case

$34.30

2,908.8%

Low target

Base Case

$43.57

+3,721.9%

Avg target

Bull Case

$49.66

+4,256.1%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$3.22

-64.6% from high

52-Week Low

$0.98

+16.3% from low

Target vs 52W High

$43.57

+1,253.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%